International Immunology Advance Access originally published online on May 20, 2005
International Immunology 2005 17(6):789-796; doi:10.1093/intimm/dxh261
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Distribution of the chromatin protein DEK distinguishes active and inactive CD21/CR2 gene in pre- and mature B lymphocytes
Department of Biology, University of Konstanz, D-78457 Konstanz, Germany
Correspondence to: H.-g. Hu; E-mail: hong-gang.hu{at}uni-konstanz.de
DEK is an abundant and ubiquitous chromatin protein that has only recently attracted attention. DEK preferentially binds to cruciform and superhelical DNA and induces positive supercoils into closed circular DNA. It is quite likely therefore that DEK performs an important architectural function in chromatin. However, it is not known how DEK is distributed in chromatin. As the first study of its kind, we investigate the distribution of DEK at the CD21/complement receptor 2 gene regulatory regions in two B lymphocyte lines, namely Ramos, which expresses the CD21 gene, and Nalm-6, which does not. We use a chromatin immunoprecipitation approach and show that DEK appears to be distributed over various regions of the expressed and silent genes, but occurs in 2- to 3-fold higher amounts at a promoter-proximal site of the expressed gene. Moreover, induction of CD21 expression in Nalm-6 cells leads to accumulation of DEK at this site. We propose that the accumulation of DEK is functionally linked to gene expression.
Keywords: CD21/CR2, chromatin immunoprecipitation, DEK, promoter
Transmitting editor: A. Radbruch
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
T. M. Wise-Draper, R. A. Mintz-Cole, T. A. Morris, D. S. Simpson, K. A. Wikenheiser-Brokamp, M. A. Currier, T. P. Cripe, G. C. Grosveld, and S. I. Wells Overexpression of the Cellular DEK Protein Promotes Epithelial Transformation In vitro and In vivo Cancer Res., March 1, 2009; 69(5): 1792 - 1799. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Wise-Draper, R. J. Morreale, T. A. Morris, R. A. Mintz-Cole, E. E. Hoskins, S. J. Balsitis, N. Husseinzadeh, D. P. Witte, K. A. Wikenheiser-Brokamp, P. F. Lambert, et al. DEK Proto-Oncogene Expression Interferes with the Normal Epithelial Differentiation Program Am. J. Pathol., January 1, 2009; 174(1): 71 - 81. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Wise-Draper, H. V. Allen, E. E. Jones, K. B. Habash, H. Matsuo, and S. I. Wells Apoptosis Inhibition by the Human DEK Oncoprotein Involves Interference with p53 Functions Mol. Cell. Biol., October 15, 2006; 26(20): 7506 - 7519. [Abstract] [Full Text] [PDF] |
||||


